Intellia Therapeutics, Inc.
NTLA
Cena:
$ 12.60
+0.23 (1.86%)
Valuace
93
Růst
23
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 14.5 mil | 13.39% | 0.60% | 1.45% | 2016-12-31 |
| VANGUARD GROUP INC | 13.0 mil | 11.81% | 0.00% | 0.00% | 2016-06-30 |
| BLACKROCK, INC. | 12.2 mil | 11.22% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK FUNDING, INC. /DE | 10.9 mil | 10.75% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK INC. | 9.6 mil | 10.05% | 0.00% | 0.00% | 2016-06-30 |
| STATE STREET CORP | 6.9 mil | 6.39% | 0.00% | 0.00% | 2016-06-30 |
| D. E. SHAW & CO., INC. | 5.7 mil | 5.29% | 0.02% | 0.04% | 2024-09-30 |
| DEEP TRACK CAPITAL, LP | 5.0 mil | 4.90% | 0.02% | 3.23% | 2022-09-30 |
| 5.1 mil | 4.69% | 0.00% | 0.00% | 2026-03-31 | |
| TWO SIGMA INVESTMENTS, LP | 4.7 mil | 4.34% | 0.01% | 0.05% | 2018-12-31 |
| CAPITAL INTERNATIONAL INVESTORS | 3.8 mil | 3.65% | 0.01% | 0.01% | 2025-03-31 |
| REGENERON PHARMACEUTICALS, INC. | 3.7 mil | 3.42% | 0.65% | 99.14% | 2024-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.9 mil | 2.63% | 0.00% | 0.00% | 2016-06-30 |
| BAKER BROS. ADVISORS LP | 2.7 mil | 2.49% | 0.10% | 0.34% | 2024-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 2.3 mil | 2.14% | 0.00% | 0.01% | 2018-09-30 |
| TWO SIGMA ADVISERS, LP | 2.3 mil | 2.13% | -0.03% | 0.04% | 2018-12-31 |
| CONTRARIUS INVESTMENT MANAGEMENT LTD | 2.0 mil | 2.03% | -0.29% | 2.39% | 2023-06-30 |
| MORGAN STANLEY | 2.1 mil | 1.92% | 0.00% | 0.00% | 2016-06-30 |
| FMR LLC | 2.1 mil | 1.91% | 0.00% | 0.00% | 2016-06-30 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 2.0 mil | 1.82% | 0.13% | 0.36% | 2018-09-30 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 2.0 mil | 1.82% | 0.00% | 0.02% | 2019-03-31 |
| CONTRARIUS GROUP HOLDINGS LTD | 1.9 mil | 1.76% | 1.08% | 1.39% | 2024-12-31 |
| JUPITER ASSET MANAGEMENT LTD | 1.8 mil | 1.64% | 0.05% | 0.12% | 2025-09-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.7 mil | 1.52% | 0.01% | 0.02% | 2023-12-31 |
| GOLDMAN SACHS GROUP INC | 1.6 mil | 1.50% | 0.00% | 0.00% | 2016-06-30 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.6 mil | 1.49% | 0.03% | 0.08% | 2020-09-30 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.4 mil | 1.38% | 0.01% | 0.03% | 2023-09-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.4 mil | 1.29% | 0.01% | 0.01% | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 1.4 mil | 1.27% | 0.00% | 0.00% | 2016-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 1.3 mil | 1.26% | 0.00% | 0.02% | 2024-03-31 |
| ROKOS CAPITAL MANAGEMENT LLP | 1.1 mil | 1.19% | -0.05% | 0.16% | 2022-03-31 |
| WOODLINE PARTNERS LP | 1.2 mil | 1.18% | 0.06% | 0.06% | 2024-09-30 |
| TREXQUANT INVESTMENT LP | 1.1 mil | 1.09% | 0.07% | 0.12% | 2024-06-30 |
| ARMISTICE CAPITAL, LLC | 1.2 mil | 1.05% | -0.05% | 0.12% | 2025-03-31 |
| STIFEL FINANCIAL CORP | 1.0 mil | 0.93% | 0.00% | 0.01% | 2020-12-31 |
| NORTHERN TRUST CORP | 966.29 tis | 0.89% | 0.00% | 0.00% | 2016-06-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 941.29 tis | 0.87% | 0.00% | 0.00% | 2016-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 699.81 tis | 0.69% | 0.00% | 0.00% | 2021-06-30 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 748.64 tis | 0.69% | 0.02% | 0.02% | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 748.10 tis | 0.69% | 0.00% | 0.00% | 2026-03-31 |
| CAPITAL FUND MANAGEMENT S.A. | 730.12 tis | 0.67% | 0.04% | 0.04% | 2024-03-31 |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 724.29 tis | 0.67% | 0.25% | 0.71% | 2024-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 637.86 tis | 0.61% | 0.00% | 0.00% | 2019-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 630.53 tis | 0.58% | 0.00% | 0.00% | 2024-12-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 582.53 tis | 0.58% | 0.00% | 0.00% | 2020-06-30 |
| MAREX GROUP PLC | 623.60 tis | 0.58% | 0.02% | 0.05% | 2025-06-30 |
| MILLENNIUM MANAGEMENT LLC | 607.56 tis | 0.55% | 0.00% | 0.00% | 2018-12-31 |
| FARALLON CAPITAL MANAGEMENT LLC | 607.20 tis | 0.55% | 0.04% | 0.04% | 2025-09-30 |
| DISCOVERY VALUE FUND | 561.56 tis | 0.54% | 1.90% | 5.66% | 2021-03-31 |
| BNP PARIBAS ARBITRAGE, SNC | 579.43 tis | 0.53% | 0.00% | 0.00% | 2016-06-30 |
| RAYMOND JAMES FINANCIAL INC | 576.93 tis | 0.53% | 0.00% | 0.00% | 2024-12-31 |
| UBS GROUP AG | 568.77 tis | 0.52% | 0.00% | 0.00% | 2025-06-30 |
| VESTAL POINT CAPITAL, LP | 525.00 tis | 0.52% | 0.36% | 0.36% | 2024-12-31 |
| VESTMARK ADVISORY SOLUTIONS, INC. | 550.14 tis | 0.51% | 0.02% | 0.08% | 2023-12-31 |
| JPMORGAN CHASE & CO | 548.49 tis | 0.51% | 0.00% | 0.00% | 2017-12-31 |
| AVIDITY PARTNERS MANAGEMENT LP | 447.43 tis | 0.50% | 0.01% | 0.50% | 2020-06-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 481.57 tis | 0.48% | 0.00% | 0.01% | 2022-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 513.40 tis | 0.47% | 0.00% | 0.00% | 2017-03-31 |
| BARCLAYS PLC | 511.24 tis | 0.46% | 0.00% | 0.00% | 2016-06-30 |
| HRT FINANCIAL LP | 502.34 tis | 0.46% | -0.01% | 0.02% | 2024-12-31 |
| PDT PARTNERS, LLC | 460.25 tis | 0.44% | -0.11% | 0.23% | 2023-09-30 |
| CAPTION MANAGEMENT, LLC | 479.90 tis | 0.44% | 0.03% | 0.04% | 2022-03-31 |
| ROYAL BANK OF CANADA | 465.50 tis | 0.43% | 0.00% | 0.00% | 2016-09-30 |
| EVENTIDE ASSET MANAGEMENT, LLC | 372.67 tis | 0.42% | -0.03% | 0.19% | 2022-09-30 |
| BIRCHVIEW CAPITAL, LP | 445.40 tis | 0.41% | 1.59% | 3.25% | 2025-06-30 |
| INVESCO LTD. | 434.75 tis | 0.40% | 0.00% | 0.00% | 2019-03-31 |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 429.54 tis | 0.40% | 0.10% | 0.42% | 2021-03-31 |
| AMERICAN CENTURY COMPANIES INC | 409.88 tis | 0.40% | 0.00% | 0.00% | 2021-06-30 |
| WELLS FARGO & COMPANY/MN | 433.74 tis | 0.39% | 0.00% | 0.00% | 2016-06-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 406.43 tis | 0.39% | 0.00% | 0.00% | 2022-03-31 |
| CUTTER CAPITAL MANAGEMENT, LP | 390.62 tis | 0.39% | 2.37% | 2.37% | 2024-09-30 |
| CITADEL ADVISORS LLC | 410.60 tis | 0.38% | 0.00% | 0.00% | 2017-09-30 |
| SPHERA FUNDS MANAGEMENT LTD. | 381.08 tis | 0.37% | -0.36% | 0.62% | 2024-06-30 |
| JANE STREET GROUP, LLC | 384.96 tis | 0.36% | 0.00% | 0.00% | 2020-06-30 |
| MARSHALL WACE, LLP | 335.41 tis | 0.35% | -0.03% | 0.01% | 2023-12-31 |
| AMERIPRISE FINANCIAL INC | 309.21 tis | 0.35% | 0.00% | 0.00% | 2020-12-31 |
| FEDERATED HERMES, INC. | 368.62 tis | 0.34% | 0.00% | 0.01% | 2020-06-30 |
| STEADFAST CAPITAL MANAGEMENT LP | 365.40 tis | 0.33% | 0.11% | 0.11% | 2025-09-30 |
| CASDIN CAPITAL, LLC | 355.00 tis | 0.33% | 0.34% | 0.34% | 2026-03-31 |
| PEAK6 LLC | 346.70 tis | 0.31% | 0.00% | 0.01% | 2024-12-31 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 342.59 tis | 0.31% | -0.11% | 0.24% | 2017-06-30 |
| EAGLE ASSET MANAGEMENT INC | 269.56 tis | 0.30% | 0.00% | 0.04% | 2021-06-30 |
| WALLEYE CAPITAL LLC | 307.20 tis | 0.30% | 0.01% | 0.01% | 2022-09-30 |
| DIADEMA PARTNERS LP | 316.90 tis | 0.29% | 0.49% | 0.49% | 2025-12-31 |
| CITIGROUP INC | 297.41 tis | 0.29% | 0.00% | 0.00% | 2016-06-30 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 315.00 tis | 0.29% | 0.00% | 0.01% | 2021-09-30 |
| CHEVY CHASE TRUST HOLDINGS, LLC | 288.32 tis | 0.29% | -0.04% | 0.01% | 2018-03-31 |
| BANK OF NEW YORK MELLON CORP | 313.05 tis | 0.28% | 0.00% | 0.00% | 2016-06-30 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 282.40 tis | 0.28% | 0.03% | 0.04% | 2024-06-30 |
| TEMASEK HOLDINGS (PRIVATE) LTD | 279.69 tis | 0.28% | -0.01% | 0.01% | 2016-06-30 |
| AFFINITY ASSET ADVISORS, LLC | 300.00 tis | 0.27% | 0.45% | 0.45% | 2025-09-30 |
| BIOIMPACT CAPITAL LLC | 267.56 tis | 0.26% | -0.72% | 0.82% | 2021-09-30 |
| PINNACLE ASSOCIATES LTD | 251.08 tis | 0.26% | -0.02% | 0.09% | 2024-03-31 |
| ALLIANCEBERNSTEIN L.P. | 265.32 tis | 0.26% | -0.01% | 0.00% | 2016-06-30 |
| VERITION FUND MANAGEMENT LLC | 271.43 tis | 0.26% | 0.01% | 0.01% | 2024-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 260.70 tis | 0.26% | 0.00% | 0.00% | 2019-06-30 |
| VOYA INVESTMENT MANAGEMENT LLC | 267.06 tis | 0.26% | 0.00% | 0.00% | 2018-06-30 |
| SQUAREPOINT OPS LLC | 245.78 tis | 0.26% | 0.01% | 0.01% | 2020-06-30 |
| ABRDN PLC | 243.04 tis | 0.25% | 0.00% | 0.01% | 2023-12-31 |
| RAFFERTY ASSET MANAGEMENT, LLC | 255.55 tis | 0.25% | 0.00% | 0.02% | 2019-03-31 |
| NORGES BANK | 240.42 tis | 0.25% | 0.00% | 0.00% | 2024-06-30 |
| JUMP FINANCIAL, LLC | 275.99 tis | 0.25% | 0.01% | 0.06% | 2023-09-30 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 238.00 tis | 0.25% | -0.01% | 0.02% | 2023-12-31 |
| DEUTSCHE BANK AG\ | 251.56 tis | 0.24% | 0.00% | 0.00% | 2016-06-30 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 217.39 tis | 0.24% | 0.01% | 0.02% | 2019-09-30 |
| OPALEYE MANAGEMENT INC. | 218.00 tis | 0.23% | -0.41% | 1.11% | 2023-06-30 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 203.68 tis | 0.23% | -0.10% | 0.24% | 2022-03-31 |
| RAYMOND JAMES & ASSOCIATES | 207.30 tis | 0.22% | 0.00% | 0.00% | 2019-12-31 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 211.37 tis | 0.21% | 0.00% | 0.01% | 2024-06-30 |
| CAPITAL ADVISORS INC/OK | 203.78 tis | 0.20% | -0.06% | 0.08% | 2021-06-30 |
| RUSSELL INVESTMENTS GROUP, LTD. | 198.51 tis | 0.20% | 0.00% | 0.01% | 2020-12-31 |
| ORCHARD CAPITAL MANAGEMENT, LLC | 172.32 tis | 0.19% | -0.23% | 1.39% | 2023-06-30 |
| SWISS NATIONAL BANK | 180.30 tis | 0.19% | 0.00% | 0.00% | 2016-12-31 |
| RHUMBLINE ADVISERS | 175.34 tis | 0.18% | 0.00% | 0.00% | 2017-06-30 |
| NEUBERGER BERMAN GROUP LLC | 171.36 tis | 0.18% | 0.00% | 0.00% | 2016-06-30 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 127.44 tis | 0.13% | 0.00% | 0.00% | 2019-09-30 |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 117.32 tis | 0.12% | 0.50% | 1.44% | 2017-12-31 |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 100.91 tis | 0.11% | 0.00% | 0.01% | 2020-09-30 |
| LEGAL & GENERAL GROUP PLC | 94.90 tis | 0.10% | 0.00% | 0.00% | 2016-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Dube Michael P | officer: VP, Chief Accounting Officer | A-Award | 17250 | 0.00 | 3.3 2026 | 69527 |
| Clark Eliana | officer: EVP, Chief Technical Officer | A-Award | 10505 | 13.78 | 3.3 2026 | 10505 |
| Clark Eliana | officer: EVP, Chief Technical Officer | S-Sale | 607 | 13.78 | 3.3 2026 | 93864 |
| Clark Eliana | officer: EVP, Chief Technical Officer | A-Award | 7353 | 0.00 | 3.3 2026 | 94471 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | A-Award | 56000 | 13.78 | 3.3 2026 | 56000 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | A-Award | 39200 | 0.00 | 3.3 2026 | 137733 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 87543 | 13.78 | 3.3 2026 | 87543 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 61280 | 0.00 | 3.3 2026 | 160963 |
| Lebwohl David | officer: EVP, Chief Medical Officer | A-Award | 14204 | 13.78 | 3.3 2026 | 14204 |
| Lebwohl David | officer: EVP, Chief Medical Officer | A-Award | 9943 | 0.00 | 3.3 2026 | 131192 |
| BASTA JAMES | officer: EVP, General Counsel | A-Award | 65829 | 13.78 | 3.3 2026 | 65829 |
| BASTA JAMES | officer: EVP, General Counsel | S-Sale | 1211 | 13.78 | 3.3 2026 | 156794 |
| BASTA JAMES | officer: EVP, General Counsel | A-Award | 46080 | 0.00 | 3.3 2026 | 158005 |
| LEONARD JOHN M | director, officer: President and CEO | A-Award | 225400 | 13.78 | 3.3 2026 | 225400 |
| LEONARD JOHN M | director, officer: President and CEO | A-Award | 156400 | 0.00 | 3.3 2026 | 1169739 |
| Dube Michael P | officer: VP, Chief Accounting Officer | S-Sale | 2989 | 9.21 | 7.1 2026 | 52277 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | S-Sale | 6379 | 9.21 | 7.1 2026 | 99683 |
| Clark Eliana | officer: EVP, Chief Technical Officer | S-Sale | 9515 | 9.21 | 7.1 2026 | 87118 |
| Lebwohl David | officer: EVP, Chief Medical Officer | S-Sale | 11903 | 9.21 | 7.1 2026 | 121249 |
| Cohen Fred E | director | P-Purchase | 150000 | 9.35 | 7.1 2026 | 207453 |
| BASTA JAMES | officer: EVP, General Counsel | S-Sale | 10397 | 9.21 | 7.1 2026 | 101528 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | S-Sale | 8508 | 9.21 | 7.1 2026 | 98533 |
| LEONARD JOHN M | director, officer: President and CEO | S-Sale | 34146 | 9.21 | 7.1 2026 | 1013339 |
| LEONARD JOHN M | director, officer: President and CEO | M-Exempt | 8557 | 6.83 | 12.12 2025 | 0 |
| LEONARD JOHN M | director, officer: President and CEO | M-Exempt | 49959 | 6.83 | 12.12 2025 | 8557 |
| LEONARD JOHN M | director, officer: President and CEO | S-Sale | 5355 | 9.59 | 12.12 2025 | 1038928 |
| LEONARD JOHN M | director, officer: President and CEO | S-Sale | 32832 | 9.47 | 12.12 2025 | 1044283 |
| LEONARD JOHN M | director, officer: President and CEO | M-Exempt | 8557 | 6.83 | 12.12 2025 | 1047485 |
| LEONARD JOHN M | director, officer: President and CEO | S-Sale | 49959 | 9.49 | 12.12 2025 | 1077115 |
| LEONARD JOHN M | director, officer: President and CEO | M-Exempt | 49959 | 6.83 | 12.12 2025 | 1127074 |
| Dube Michael P | officer: VP, Chief Accounting Officer | S-Sale | 1871 | 17.38 | 3.10 2025 | 55266 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | S-Sale | 31 | 17.38 | 3.10 2025 | 105184 |
| CHASE WILLIAM J | director | P-Purchase | 100000 | 10.03 | 22.8 2025 | 134693 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | S-Sale | 7462 | 14.02 | 25.7 2025 | 106062 |
| Dube Michael P | officer: VP, Chief Accounting Officer | S-Sale | 2503 | 9.95 | 3.7 2025 | 57137 |
| Clark Eliana | officer: EVP, Chief Technical Officer | S-Sale | 1022 | 9.82 | 3.7 2025 | 95369 |
| GOODMAN JESSE | director | S-Sale | 1547 | 9.23 | 2.7 2025 | 24359 |
| GOODMAN JESSE | director | S-Sale | 1547 | 9.56 | 2.7 2025 | 25906 |
| Keresty Georgia | director | A-Award | 11450 | 8.37 | 18.6 2025 | 11450 |
| Keresty Georgia | director | A-Award | 8000 | 0.00 | 18.6 2025 | 31883 |
| Cohen Fred E | director | A-Award | 11450 | 8.37 | 13.6 2025 | 11450 |
| Cohen Fred E | director | A-Award | 8000 | 0.00 | 13.6 2025 | 57453 |
| CHASE WILLIAM J | director | A-Award | 11450 | 8.37 | 13.6 2025 | 11450 |
| CHASE WILLIAM J | director | A-Award | 8000 | 0.00 | 13.6 2025 | 34693 |
| Bhanji Muna | director | A-Award | 11450 | 8.37 | 13.6 2025 | 11450 |
| Bhanji Muna | director | A-Award | 8000 | 0.00 | 13.6 2025 | 27203 |
| Goff Brian | director | A-Award | 11450 | 8.37 | 13.6 2025 | 11450 |
| Goff Brian | director | A-Award | 8000 | 0.00 | 13.6 2025 | 23409 |
| GOODMAN JESSE | director | A-Award | 11450 | 8.37 | 13.6 2025 | 11450 |
| GOODMAN JESSE | director | A-Award | 8000 | 0.00 | 13.6 2025 | 27453 |
| Verwiel Frank | director | A-Award | 11450 | 8.37 | 13.6 2025 | 11450 |
| Verwiel Frank | director | A-Award | 8000 | 0.00 | 13.6 2025 | 25948 |
| Bhanji Muna | director | S-Sale | 265 | 8.50 | 1.5 2025 | 19203 |
| BASTA JAMES | officer: EVP, General Counsel | A-Award | 57143 | 10.09 | 4.3 2025 | 57143 |
| BASTA JAMES | officer: EVP, General Counsel | S-Sale | 2572 | 8.99 | 4.3 2025 | 111925 |
| BASTA JAMES | officer: EVP, General Counsel | A-Award | 40000 | 0.00 | 4.3 2025 | 114497 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | A-Award | 53714 | 10.09 | 4.3 2025 | 53714 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | A-Award | 37600 | 0.00 | 4.3 2025 | 105215 |
| Lebwohl David | officer: EVP, Chief Medical Officer | A-Award | 61714 | 10.09 | 4.3 2025 | 61714 |
| Lebwohl David | officer: EVP, Chief Medical Officer | A-Award | 43200 | 0.00 | 4.3 2025 | 130866 |
| Dube Michael P | officer: VP, Chief Accounting Officer | A-Award | 14000 | 0.00 | 4.3 2025 | 59640 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 67429 | 10.09 | 4.3 2025 | 67429 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 47200 | 0.00 | 4.3 2025 | 113524 |
| LEONARD JOHN M | director, officer: President and CEO | A-Award | 196000 | 10.09 | 4.3 2025 | 196000 |
| LEONARD JOHN M | director, officer: President and CEO | A-Award | 136000 | 0.00 | 4.3 2025 | 1077115 |
| Clark Eliana | officer: EVP, Chief Technical Officer | A-Award | 45714 | 10.09 | 4.3 2025 | 45714 |
| Clark Eliana | officer: EVP, Chief Technical Officer | S-Sale | 679 | 8.99 | 4.3 2025 | 95369 |
| Clark Eliana | officer: EVP, Chief Technical Officer | A-Award | 32000 | 0.00 | 4.3 2025 | 96048 |
| Bhanji Muna | director | S-Sale | 265 | 9.97 | 31.1 2025 | 19468 |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 3500 | 134.06 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 31816 | 32.66 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 20000 | 18.30 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 40000 | 27.33 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 10625 | 14.58 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 24965 | 40.75 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 20600 | 57.71 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 30000 | 13.40 | 23.1 2025 | 0 | |
| Schultes Birgit C | officer: EVP, Chief Scientific Officer | 0 | 0.00 | 23.1 2025 | 67615 | |
| Sepp-Lorenzino Laura | officer: EVP, Chief Scientific Officer | S-Sale | 8966 | 12.18 | 7.1 2025 | 77388 |
| LEONARD JOHN M | director, officer: President and CEO | S-Sale | 26807 | 12.18 | 7.1 2025 | 941115 |
| Hicks Derek | officer: EVP, Chief Business Officer | S-Sale | 6502 | 12.18 | 7.1 2025 | 59878 |
| Lebwohl David | officer: EVP, Chief Medical Officer | S-Sale | 9557 | 12.18 | 7.1 2025 | 87666 |
| BASTA JAMES | officer: EVP, General Counsel | S-Sale | 7074 | 12.18 | 7.1 2025 | 74497 |
| Dube Michael P | officer: VP, Chief Accounting Officer | S-Sale | 1372 | 12.18 | 7.1 2025 | 45640 |
| Clark Eliana | officer: EVP, Chief Technical Officer | S-Sale | 7422 | 12.18 | 6.1 2025 | 64048 |
| Clark Eliana | officer: EVP, Chief Technical Officer | S-Sale | 556 | 12.03 | 6.1 2025 | 71470 |
| LEONARD JOHN M | director, officer: President and CEO | M-Exempt | 7850 | 0.00 | 3.1 2025 | 0 |
| Sepp-Lorenzino Laura | officer: EVP, Chief Scientific Officer | M-Exempt | 3500 | 0.00 | 3.1 2025 | 0 |
| Sepp-Lorenzino Laura | officer: EVP, Chief Scientific Officer | M-Exempt | 3500 | 0.00 | 3.1 2025 | 86354 |
| LEONARD JOHN M | director, officer: President and CEO | M-Exempt | 7850 | 0.00 | 3.1 2025 | 967922 |
| Lebwohl David | officer: EVP, Chief Medical Officer | M-Exempt | 3189 | 0.00 | 3.1 2025 | 0 |
| Lebwohl David | officer: EVP, Chief Medical Officer | M-Exempt | 3189 | 0.00 | 3.1 2025 | 97223 |
| Dube Michael P | officer: VP, Chief Accounting Officer | S-Sale | 2012 | 19.01 | 4.10 2024 | 47012 |
| Dulac Edward J III | 0 | 0.00 | 24.7 2024 | 0 | ||
| Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 66324 | 0.00 | 24.7 2024 | 66324 |
| Dulac Edward J III | officer: EVP, Chief Financial Officer | A-Award | 96219 | 25.33 | 24.7 2024 | 96219 |
| Dube Michael P | officer: VP, PAO and Interim PFO | A-Award | 17801 | 0.00 | 3.7 2024 | 49024 |
| Clark Eliana | officer: EVP, Chief Technical Officer | S-Sale | 405 | 22.93 | 3.7 2024 | 71470 |
| Verwiel Frank | director | S-Sale | 1505 | 25.00 | 20.6 2024 | 17948 |
| Goff Brian | 0 | 0.00 | 17.6 2024 | 0 |
